[HTML][HTML] The therapeutic efficacy of 177Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis
L Wang, L Lin, M Wang, Y Li - Medicine, 2020 - journals.lww.com
Background: Somatostatin analog therapies showed great potential for patients suffering
advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic …
advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic …
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors
P Brunner, AC Jörg, K Glatz, L Bubendorf… - European journal of …, 2017 - Springer
Purpose Our aim was to assess the prognostic and predictive value of somatostatin receptor
2 (sstr 2) in neuroendocrine tumors (NETs). Methods We established a tissue microarray …
2 (sstr 2) in neuroendocrine tumors (NETs). Methods We established a tissue microarray …
Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion …
EA Carlsen, CB Johnbeck, M Loft… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Patients with neuroendocrine neoplasms (NENs) have heterogeneous somatostatin
receptor expression, with highly differentiated lesions having higher expression. Receptor …
receptor expression, with highly differentiated lesions having higher expression. Receptor …
Nuclear imaging of neuroendocrine tumours
A Sundin, U Garske, H Örlefors - Best practice & research Clinical …, 2007 - Elsevier
The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …
patients relies mainly on morphological imaging techniques such as computed tomography …
[HTML][HTML] Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
E Alevroudis, ME Spei, SN Chatziioannou, M Tsoli… - Cancers, 2021 - mdpi.com
Simple Summary Functional imaging with 18F-fluorodeoxyglucose positron emission
tomography (18F-FDG PET) has evolved into a major clinical tool in cancer diagnosis and …
tomography (18F-FDG PET) has evolved into a major clinical tool in cancer diagnosis and …
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
Purpose The prognostic value of FDG PET for neuroendocrine tumours (NETs) has been
reported. In this study we evaluated the role of FDG PET in predicting response and …
reported. In this study we evaluated the role of FDG PET in predicting response and …
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
I Buchmann, M Henze, S Engelbrecht… - European journal of …, 2007 - Springer
Abstract Purpose Neuroendocrine tumours (NETs) can be imaged with scintigraphy using
radiolabelled somatostatin analogues. The aim of our study was to compare the value of 68 …
radiolabelled somatostatin analogues. The aim of our study was to compare the value of 68 …
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging
A Sundin, R Arnold, E Baudin, JB Cwikla… - …, 2017 - karger.com
Contrast-enhanced computed tomography (CT) of the neck-thorax-abdomen and pelvis,
including 3-phase examination of the liver, constitutes the basic imaging for primary …
including 3-phase examination of the liver, constitutes the basic imaging for primary …
[HTML][HTML] Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy
RJ Hicks - Cancer imaging, 2010 - ncbi.nlm.nih.gov
Imaging of neuroendocrine tumours (NET) poses significant challenges because of the
heterogeneous biology of the tumours that are represented by this class of neoplasia .NET …
heterogeneous biology of the tumours that are represented by this class of neoplasia .NET …
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta …
Abstract Gallium-68 somatostatin receptor (SMSR) positron emission tomography (PET) and
positron emission tomography/computed tomography (PET/CT) are valuable diagnostic …
positron emission tomography/computed tomography (PET/CT) are valuable diagnostic …